Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

The aim of this pilot study is to evaluate the feasibility of conducting a randomized placebo-controlled study to determine the opioid sparing and analgesic effect of vitamin C c

Original research | 2024
Hospitals, Opioids, Outcomes

To determine how human brain network changes relate to subjective and lasting effects of psychedelics.

Original research | 2024
Hallucinogens/psychedelics, Mental health, Stimulants

Traumatic brain injury (TBI) is a leading cause of disability.

Original research | 2024
Chronic disease, Evidence base, Hallucinogens/psychedelics, Illegal drugs, Mental health

This study leveraged new Cannabis use disorder (CanUD) genomics data to undertake genetically-informed analyses with unprecedented power, to investigate the genetic architecture and causal relation

Original research | 2024
Alcohol, Cannabis, Opioids, Outcomes

The aim of this paper is to examine known and potential wound-associated agents’ (xylazine, levamisole, medetomidine) prevalence in Maryland's unregulated drug supply.

Original research | 2025
Drug checking, Harm reduction, Illegal drugs, Overdose, Xylazine

To investigate if “before medically advised” (BMA) discharge from hospital increases the risk of subsequent drug overdose.

Original research | 2024
About PWUD, Hospitals, Illegal drugs, Mortality, Overdose

Safer opioid supply programs in Canada have come under intense scrutiny related to the perceived risk of diversion of safer opioid supply medications.

Original research | 2024
About PWUD, Advocacy, Barriers and enablers, Diversion, Harm reduction, Illegal drugs, Opioids, Overdose, Peer/PWLLE program involvement, Safer supply

To examine provider (prescribing clinicians and allied health professionals) and patient perspectives on diversion of opioids prescribed in safer supply programs.

Original research | 2024
About prescribers, About PWUD, Advocacy, Barriers and enablers, Diversion, Harm reduction, Safer supply

From August 2022 until October 2023, the Drug User Liberation Front [DULF] operated a drug compassion club [CC], which sells drugs of known composition and purity without medical oversight.

Original research | 2024
About PWUD, Advocacy, Barriers and enablers, Drug checking, Harm reduction, Illegal drugs, Mortality, Opioids, Overdose, Peer/PWLLE program involvement, Safer supply, Stimulants

This article describes the implementation and evaluation of four Safer Opioid Supply programs (SSPs) in Ontario, one in London and three in Toronto.

Original research | 2024
Barriers and enablers, Diversion, Clinical guidance, Harm reduction, Illegal drugs, Safer supply, Substitution/OAT, Wrap-around services, Overdose

Polysubstance use is highly prevalent among persons who use cocaine; however, little is known about how alcohol and cannabis are used with cocaine. 

Original research | 2024
About PWUD, Alcohol, Cannabis, Illegal drugs, Stimulants

What is the association between cannabis use during adolescence or young adulthood and academic achievement?

Lit review | 2024
About PWUD, Cannabis, Youth
Commentary | 2024
About PWUD, Clinical guidance, Illegal drugs, Mental health, Overdose, Opioids, Xylazine

This study examined the effectiveness of a community-engaged intervention to reduce opioid-related overdose deaths through enhanced uptake of evidence-based overdose prevention practices.

Original research | 2024
About PWUD, Harm reduction, Illegal drugs, Mortality, Overdose, Substitution/OAT

To evaluate whether augmenting medication for opioid use disorder (MOUD) with smartphone app–based contingency management (CM) is associated with fewer days of opioid use at the end of treatment an

Original research | 2024
About PWUD, Evidence base, Opioids, Return to use, Substitution/OAT, Treatment/recovery

This study examined whether Illicitly manufactured fentanyl (IMF) use predicts hepatitis C virus (HCV) and human immunodeficiency virus (HIV) incidence among a cohort of people who inject drugs (PW

Original research | 2024
About PWUD, Fentanyl, Illegal drugs, Injecting drugs

This study aims were to describe trends in accidental stimulant toxicity deaths and to characterize demographic characteristics of decedents and the circumstances surrounding death.

Original research | 2025
About PWUD, Harm reduction, Illegal drugs, Mortality, Opioids, Overdose, Peer/PWLLE program involvement, Stimulants

The Government of Ontario has announced plans to close five of 10 sites in Toronto by March 2025, and another site is likely to close after its lease expires.

Report | 2024
Advocacy, Barriers and enablers, Harm reduction, Injecting drugs, Opioids, Policy/Regulatory, SCS/OPS, Stimulants
Report | 2024
Barriers and enablers, Equity, Illegal drugs, Harm reduction, Overdose, Peer/PWLLE program involvement, Safer supply, Stigma, Substitution/OAT, Treatment/recovery, Wrap-around services
Report | 2024
About people who use drugs, Advocacy, Barriers and enablers, Decriminalization/legalization, Equity, Harm reduction, Housing, Illegal drugs, Legal system/law enforcement, Overdose, Peer/PWLLE program involvement, Rural/remote, Safer supply

Refine Your Search

Keywords
Format
Region